Use of antiviral may be fuelling evolution of Covid, scientists say
Study finds evidence virus can survive treatment with molnupiravir, leading to mutated versions that sometimes spreadAn antiviral drug used to treat patients with Covid-19 may be causing mutations in the virus and fuelling the evolution of new variants, scientists have said.Molnupiravir, which is also sold under the brand name Lagevrio, is designed to mutate coronavirus to destruction, but researchers found evidence that the virus can sometimes …
Warning as popular Covid antiviral drug is driving unexpected mutations
Molnupiravir was one of the first antivirals available on the market during the COVID-19 pandemic, and was employed by many countries, including the US, particularly against chronic infections.
Anti-Covid drug may have led to virus mutations: study
Pharmaceutical giant Merck’s antiviral pill molnupiravir was one of the earliest treatments rolled out during the pandemic to prevent Covid becoming more severe in vulnerable people.
Anti-COVID drug may have led to virus mutations: Study
PARIS: An anti-COVID drug widely used across the world may have caused mutations in the virus, researchers said on Monday (Sep 25), but there was no evidence that the changes had led to more dangerous variants. Pharmaceutical giant Merck's antiviral pill molnupiravir was one of the earliest treatments
- 62% of the sources are Center
To view factuality data please Upgrade to Premium
To view ownership data please Upgrade to Vantage